Upgrade to SI Premium - Free Trial

Piper Jaffray Downgrades Teva Pharma (TEVA) to Underweight

February 9, 2018 5:04 AM
Piper Jaffray downgraded Teva Pharma (NYSE: TEVA) from Neutral to Underweight with a price target of $11.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Downgrades Hot Downgrades

Next Articles